B.663 (Geigy 30. 320) in the treatment of leprosy. A preliminary report.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001893:Borneo; D002648:Child; D005260:Female; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010619:Phenazines / Q000009:adverse effects / Q000627:therapeutic use*; D010859:Pigmentation Disorders / Q000139:chemically induced
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D010619:Phenazines